International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(23), С. 12738 - 12738
Опубликована: Ноя. 27, 2024
Cannabis
sativa
L.
contains
numerous
compounds
with
antioxidant
and
anti-inflammatory
properties,
including
the
flavonoids
cannabinoids,
particularly
Δ-9-tetrahydrocannabinol
(THC)
cannabidiol
(CBD).
Cannabinoids
have
an
effect
on
endocannabinoid
system
(ECS),
a
cellular
communication
network,
are,
hence,
widely
studied
for
medical
applications.
Epidiolex®,
99%
pure
oral
CBD
extract,
has
been
approved
by
FDA
treatment
of
epilepsy.
Nabiximols
(Sativex)
is
oromucosal
spray
containing
equal
volume
THC
CBD,
it
commonly
used
as
add-on
unresponsive
spasticity
in
multiple
sclerosis
(MS)
patients.
Several
vitro
vivo
studies
also
shown
that
cannabinoids
can
be
to
treat
various
types
cancer,
such
melanoma
brain
glioblastoma;
first
positive
clinical
trials
anticancer
THC:CBD
blend
temozolomide
(TMZ)
highly
invasive
cancer
are
very
promising.
The
exert
their
properties
investigations
induction
cell
death,
mainly
apoptosis
cytotoxic
autophagy,
inhibition
proliferation.
In
several
studies,
found
induce
tumor
regression
inhibit
angiogenic
mechanisms
vivo,
well
two
low-numbered
epidemiological
studies.
They
exhibit
antiviral
effects
inhibiting
ACE2
transcription,
blocking
viral
replication
fusion,
acting
agents;
indeed,
prior
consumption
(a
study
93,565
persons
Chicago)
associated
much
lower
incidence
SARS-CoV-2
infections.
It
postulated
cannabis
extracts
many
other
diseases
systemic
lupus
erythematosus,
type
1
diabetes,
or
neurological
disorders,
e.g.,
Alzheimer’s
disease.
aim
this
review
outline
current
state
knowledge
regarding
currently
medicinal
preparations
derived
from
C.
selected
diseases,
present
latest
research
potential
applications
its
secondary
metabolites.
Journal of Cannabis Research,
Год журнала:
2023,
Номер
5(1)
Опубликована: Июнь 13, 2023
Abstract
The
use
of
cannabidiol
(CBD)
for
therapeutic
purposes
is
receiving
considerable
attention,
with
speculation
that
CBD
can
be
useful
in
a
wide
range
conditions.
Only
one
product,
purified
form
plant-derived
solution
(Epidiolex),
approved
the
treatment
seizures
patients
Lennox-Gastaut
syndrome,
Dravet
or
tuberous
sclerosis
complex.
Appraisal
evidence
base
complicated
by
fact
products
sometimes
have
additional
phytochemicals
(like
tetrahydrocannabinol
(THC))
present,
which
make
identification
active
pharmaceutical
ingredient
(API)
positive
studies
difficult.
aim
present
review
to
critically
clinical
using
only,
order
establish
upcoming
indications
might
beneficial.
areas
there
most
support
are
anxiety
(positive
data
7
uncontrolled
and
17
randomised
controlled
trials
(RCTs)),
psychosis
schizophrenia
1
study
8
RCTs),
PTSD
2
4
RCTs)
substance
abuse
3
RCTs).
Seven
improve
sleep
quality,
but
this
has
only
been
verified
small
RCT.
Limited
supports
Parkinson’s
(3
autism
smoking
cessation
(2
graft-versus-host
disease
intestinal
permeability
(1
RCT
each).
Current
does
not
oral
pain
(at
least
as
an
acute
analgesic)
COVID
symptoms,
cancer,
Huntington’s
type
diabetes.
In
conclusion,
published
multiple
beyond
epilepsy.
However,
limited
number
investigating
effects
CBD,
testing
healthy
volunteers,
very
patient
numbers.
Large
confirmatory
phase
required
all
indications.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(6), С. 5251 - 5251
Опубликована: Март 9, 2023
Cannabis
is
the
most
used
drug
of
abuse
worldwide.
It
well
established
that
abundant
phytocannabinoids
in
this
plant
are
Δ9-tetrahydrocannabinol
(THC)
and
cannabidiol
(CBD).
These
two
compounds
have
remarkably
similar
chemical
structures
yet
vastly
different
effects
brain.
By
binding
to
same
receptors,
THC
psychoactive,
while
CBD
has
anxiolytic
antipsychotic
properties.
Lately,
a
variety
hemp-based
products,
including
THC,
become
widely
available
food
health
industry,
medical
recreational
use
cannabis
been
legalized
many
states/countries.
As
result,
people,
youths,
consuming
because
it
considered
“safe”.
An
extensive
literature
exists
evaluating
harmful
both
adults
adolescents,
but
little
known
about
long-term
exposure,
especially
adolescence.
The
aim
review
collect
preclinical
clinical
evidence
cannabidiol.
Journal of Neuroscience,
Год журнала:
2019,
Номер
39(44), С. 8762 - 8777
Опубликована: Сен. 30, 2019
Evidence
suggests
that
the
phytocannabinoids
Δ-9-tetrahydrocannabinol
(THC)
and
cannabidiol
(CBD)
differentially
regulate
salience
attribution
psychiatric
risk.
The
ventral
hippocampus
(vHipp)
relays
emotional
via
control
of
dopamine
(DA)
neuronal
activity
states,
which
are
dysregulated
in
psychosis
schizophrenia.
Using
vivo
electrophysiology
male
Sprague
Dawley
rats,
we
demonstrate
intra-vHipp
THC
strongly
increases
tegmental
area
(VTA)
DA
frequency
bursting
rates,
decreases
GABA
frequency,
amplifies
VTA
beta,
gamma
ε
oscillatory
magnitudes
modulation
local
extracellular
signal-regulated
kinase
phosphorylation
(pERK1–2).
Remarkably,
whereas
also
potentiates
morphine
place-preference
fear
conditioning
assays,
CBD
coadministration
reverses
these
changes
by
downregulating
pERK1–2
signaling,
as
pharmacological
reactivation
blocked
inhibitory
properties
CBD.
These
results
identify
vHipp
signaling
a
critical
neural
nexus
point
mediating
THC-induced
affective
disturbances
suggest
potential
mechanism
may
counteract
psychotomimetic
psychotropic
side
effects
THC.
SIGNIFICANCE
STATEMENT
Strains
marijuana
with
high
levels
delta-9-tetrahydrocannabinol
low
have
been
shown
to
underlie
neuropsychiatric
risks
associated
high-potency
cannabis
use.
However,
mechanisms
mitigates
not
identified.
We
induces
cognitive
abnormalities
resembling
symptoms
directly
hippocampus,
while
dysregulating
states
amplifying
frequencies
(ERK)
pathway.
In
contrast,
ERK
phosphorylation,
prevented
behavioral
abnormalities.
findings
novel
molecular
account
for
how
functionally
Phytomedicine,
Год журнала:
2021,
Номер
94, С. 153823 - 153823
Опубликована: Окт. 25, 2021
Epidemiological
and
clinical
evidence
suggests
that
diabetes
increases
the
risk
of
liver
cancer.
Although
co-occurrence
type
2
(T2D)
cancer
is
becoming
more
frequent,
underlying
mechanisms
remain
unclear.
Even
though
baicalin,
extensively
used
in
traditional
Chinese
medicine
(TCM),
can
control
T2D
inhibit
separately,
minimal
research
available
regarding
its
possible
effect
on
T2D-induced
Thus,
present
study,
we
aimed
to
investigate
role
baicalin
hepatocellular
cancer,
for
first
time,
particularly
emphasized
regulation
genes
RNA
m6A
cancer.Here,
constructed
a
cell
culture
model
under
high
concentration
glucose
tumor
evaluate
vitro
vivo
progression.
After
confirming
suppressive
HKDC1
antibody
tumors,
epigenetic
alterations
(DNA
5mC
m6A)
baicalin-regulated
gene
were
detected
using
MS
q-PCR.
Next,
METTL3
gene-regulated
(2854
site)
was
investigated
SELECT
PCR.
Finally,
impact
other
three
analogs
(baicalein,
wogonoside,
wogonin)
inhibition
tested
while
verifying
related
mechanism.The
results
showed
suppressed
progression
vivo.
Furthermore,
significantly
inhibited
modification
HepG2
mainly
targeting
site
(2854).
The
m6A-related
gene,
METTL3,
regulated
(2854)
HKDC1,
which
also
restricted
by
baicalin.
Moreover,
study
verified
METTL3/HKDC1/JAK2/STAT1/caspase-3
pathway
cells
when
exposed
concentration.
In
addition,
proven
regulate
suppress
tumors.The
findings
this
revealed
regulating
METTL3/m6A/HKDC1
axis,
might
support
potential
application
preventing
treating
Comprehensive Reviews in Food Science and Food Safety,
Год журнала:
2021,
Номер
20(3), С. 2382 - 2427
Опубликована: Март 14, 2021
Abstract
Seeds
play
important
roles
in
human
nutrition
and
health
since
ancient
time.
The
term
“specialty”
has
recently
been
applied
to
seeds
describe
high‐value
and/or
uncommon
food
products.
Since
then,
numerous
studies
have
conducted
identify
various
classes
of
bioactive
compounds,
including
polyphenols
specialty
seeds.
This
review
discusses
nutrients,
fat‐soluble
bioactives,
polyphenols/bioactives,
antioxidant
activity,
bioavailability,
benefits,
safety/toxicology
commonly
consumed
eight
seeds,
namely,
black
cumin,
chia,
hemp,
flax,
perilla,
pumpkin,
quinoa,
sesame.
Scientific
results
from
the
existing
literature
published
over
last
decade
compiled
discussed.
These
having
bioactives
polyphenols,
together
with
their
corresponding
activities,
increasingly
consumed.
Hence,
these
can
be
considered
as
a
valuable
source
dietary
supplements
functional
foods
due
health‐promoting
components,
activities.
phytochemicals
demonstrate
bioavailability
humans
promising
benefits.
Additional
long‐term
well‐design
intervention
trials
are
required
ascertain
properties
Food Science & Nutrition,
Год журнала:
2021,
Номер
9(7), С. 3777 - 3805
Опубликована: Июнь 1, 2021
In
the
present
study,
aerial
parts
of
Achyranthes
ferruginea
underwent
investigation
their
in
vitro
antioxidant
and
free
radical-scavenging
activities
cell-free
conditions,
phytoconstituents
using
gas
chromatography-mass
spectrometry
(GC-MS),
cytotoxic
activity
HeLa
cells.
A.
was
extracted
with
80%
methanol
successively
fractionated
solvents
to
yield
petroleum
ether
(PEF),
chloroform
(CHF),
ethyl
acetate
(EAF),
aqueous
(AQF)
fractions.
GC-MS
analysis
revealed
that
CHF
contained
ten
phytoconstituents,
including
different
forms
octadecanoic
acid
methyl
esters.
The
total
ferric-reducing
capacities
extracts
standard
catechin
(CA)
were
as
follows:
CA
>CHF
>PEF
>CME
(crude
methanolic
extract)
>EAF
>AQF,
>AQF
>CME,
respectively.
showed
highest
DPPH-free
activity,
a
median
inhibitory
concentration
10.5
±
0.28
µg/ml,
which
slightly
higher
than
butylated
hydroxytoluene
(12.0
0.09
µg/ml).
hydroxyl
assay,
identical
scavenging
(9.25
0.73
µg/ml)
when
compared
(10.50
1.06
Moreover,
strong
(19.95
1.18
cells,
alike
standards
vincristine
sulfate
5-fluorouracil
(15.84
1.64
µg/ml
12.59
1.75
respectively).
silico
study
identified
compounds
significantly
linked
targets
various
cancer
cells
oxidative
enzymes.
However,
online
prediction
by
SwissADME,
admetSAR,
PASS
it
has
drug-like,
nontoxic,
potential
pharmacological
actions.
Planta Medica,
Год журнала:
2021,
Номер
88(07), С. 492 - 506
Опубликована: Апрель 13, 2021
Abstract
The
use
of
Cannabis
sativa
is
currently
recognized
to
ease
certain
types
chronic
pain,
reduce
chemotherapy-induced
nausea,
and
improve
anxiety.
Nevertheless,
few
studies
highlighted
the
therapeutic
potential
C.
extracts
related
phytocannabinoids
for
a
variety
widespread
skin
disorders
including
acne,
atopic
dermatitis,
psoriasis,
pruritus,
pain.
This
review
summarized
current
evidence
on
effects
at
cutaneous
level
through
collection
in
vitro,
vivo,
clinical
published
PubMed,
Scopus,
Embase,
Web
Science
until
October
2020.
Phytocannabinoids
have
demonstrated
anti-inflammatory,
antioxidant,
anti-aging,
anti-acne
properties
by
various
mechanisms
involving
either
CB1/2-dependent
independent
pathways.
Not
only
classical
immune
cells,
but
also
several
skin-specific
actors,
such
as
keratinocytes,
fibroblasts,
melanocytes,
sebocytes,
may
represent
target
phytocannabinoids.
Cannabidiol,
most
investigated
compound,
revealed
photoprotective,
anti-inflammatory
level,
while
possible
impact
cell
differentiation,
especially
case
would
require
further
investigation.
Animal
models
pilot
supported
application
cannabidiol
inflammatory-based
diseases.
Also,
one
promising
applications
non-psychotropic
treatment
seborrheic
disorders,
acne.
In
conclusion,
incomplete
knowledge
role
endocannabinoid
system
emerged
an
important
limit
pharmacological
investigations.
Moreover,
limited
conducted
suggested
higher
potency
than
single
phytocannabinoids,
thus
stimulating
new
research
phytocannabinoid
interaction.
Cancers,
Год журнала:
2022,
Номер
14(20), С. 5142 - 5142
Опубликована: Окт. 20, 2022
The
endocannabinoid
system
(ECS)
is
an
ancient
homeostasis
mechanism
operating
from
embryonic
stages
to
adulthood.
It
controls
the
growth
and
development
of
many
cells
cell
lineages.
Dysregulation
components
ECS
may
result
in
uncontrolled
proliferation,
adhesion,
invasion,
inhibition
apoptosis
increased
vascularization,
leading
various
malignancies.
Cancer
disease
division.
In
this
review,
we
will
discuss
whether
changes
are
a
cause
or
consequence
malignization
different
tissues
react
differently
ECS.
We
potential
use
cannabinoids
for
treatment
cancer,
focusing
on
primary
outcome/care—tumor
shrinkage
eradication,
as
well
secondary
outcome/palliative
care—improvement
life
quality,
including
pain,
appetite,
sleep,
more
factors.
Finally,
complete
review
with
chapter
sex-
gender-specific
differences
response
cannabinoids,
equality
access
treatments
cannabinoids.
Plants,
Год журнала:
2022,
Номер
11(23), С. 3330 - 3330
Опубликована: Дек. 1, 2022
The
published
health
benefits
of
Cannabis
sativa
has
caught
the
attention
health-conscious
consumers
and
food
industry.
Historically,
seeds
have
long
been
utilized
as
a
source
currently
there
is
an
increasing
number
edibles
on
market
that
contain
cannabis.
Cannabinoids
include
psychoactive
constituent,
delta-9-tetrahydrocannabinol
(THC),
non-psychoactive
cannabidiol
(CBD)
are
both
compounds
interest
in
sativa.
This
paper
looks
at
distribution
nutrients
phytocannabinoids
low-THC
sativa,
historical
uses
hemp,
cannabis
edibles,
possible
side-effects
concerns
related
to
edibles.
Several
authors
pointed
out
even
though
use
considered
safe,
it
important
mention
their
any
its
consumption
negatively
influence
consumer
acceptance
Such
risks
unintentional
overdose
by
adults
accidental
ingestion
children
adolescents
resulting
serious
adverse
effects.
Therefore,
should
be
specifically
packaged
labelled
differentiate
them
from
known
similar
non-cannabis
so
that,
together
with
tamperproof
packaging,
these
measures
reduce
appeal
products
children.